Journal of Animal Reproduction and Biotechnology (한국동물생명공학회지)

The Korean Society of Animal Reproduction and Biotechnology (한국동물생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Stem cell therapy for dogs with immune-mediated hemolytic anemia

  • Yeonmi Lee (Department of Biomedical Science, College of Life Science, CHA University) ;
  • Eunju Kang (Department of Biomedical Science, College of Life Science, CHA University) ;
  • Junguk Ju (AniCom Therapeutics Inc)
  • Received : 2023.11.07
  • Accepted : 2023.11.19
  • Published : 2024.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Three different dogs who had immune-mediated hemolytic anemia (IMHA) were treated for more than two weeks with blood transfusion in an animal clinic. Despite this treatment and hospitalization, there was no clinical improvement in clinical signs as well as complete blood cell count (CBC) including hematocrit (HCT) and C-reactive protein (CRP). All cases were then injected two or three times with allogeneic stem cells through an intravenous route for treatment. Upon administrating stem cells to the IMHA dogs, clinical conditions and the indexes of HCT and CRP were clinically improved within or close to normal ranges.

Keywords

References

  1. Assenmacher TD, Jutkowitz LA, Koenigshof AM, de A Lucidi C, Scott MA. 2019. Clinical features of precursor-targeted immune-mediated anemia in dogs: 66 cases (2004-2013). J. Am. Vet. Med. Assoc. 255:366-376.  https://doi.org/10.2460/javma.255.3.366
  2. Balch A and Mackin A. 2007. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis. Compend. Contin. Educ. Vet. 29:217-225. 
  3. Dizaji Asl K, Shafaei H, Soleimani Rad J, Nozad HO. 2017. Comparison of characteristics of human amniotic membrane and human adipose tissue derived mesenchymal stem cells. World J. Plast. Surg. 6:33-39. 
  4. Garner SD. 2022. Allogenic mesenchymal stem cell therapy for immune mediated cytopenias - a 22 case series. Safari Veterinary Care Centers. https://stemcellsafari.com/clinicalreports/22-cases-of-imha-review
  5. Insausti CL, Blanquer M, Garcia-Hernandez AM, Castellanos G, Moraleda JM. 2014. Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning 7:53-63. 
  6. Kim T, Noh SA, Ju J. 2021. Case report of amniotic membrane derived-stem cells treatment for feline chronic obstructive pulmonary disease. J. Anim. Reprod. Biotechnol. 36:323-326.  https://doi.org/10.12750/JARB.36.4.323
  7. Ma J, Wu J, Han L, Jiang X, Yan L, Hao J, Wang H. 2019. Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition. Stem Cell Res. Ther. 10:19. 
  8. Noh SA, Kim T, Ju J. 2021. Case reports of amniotic membrane derived-cell treatment for feline chronic renal failure. J. Anim. Reprod. Biotechnol. 36:116-120.  https://doi.org/10.12750/JARB.36.2.116
  9. Sharp C and Kerl ME. 2008. Immune-mediated hemolytic anemia. Stand. Care Emerg. Crit. Care Med. 10:1-6. 
  10. Swann JW, Garden OA, Fellman CL, Glanemann B, Goggs R, LeVine DN, Mackin AJ, Whitley NT. 2019. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs. J. Vet. Intern. Med. 33:1141-1172. https://doi.org/10.1111/jvim.15463